Exercise-Induced Mitochondrial Biogenesis Signaling
Placeholder: endurance exercise activates PGC-1alpha to build new mitochondria.
- AMPK: Primary sensor (Placeholder short note)
- PGC-1α: Master regulator (Placeholder short note)
- 2–6 h: Response window (Placeholder short note)
- Biogenesis: Adaptation type (Placeholder short note)
Placeholder heading: exercise signaling cascade
Placeholder short paragraph describing AMPK/PGC-1alpha exercise signaling cascade.
Metformin's AMPK Overlap with the Exercise Pathway
Placeholder: metformin activates the same AMPK node exercise uses.
- AMPK activation: Mechanism (Placeholder short note)
- Skeletal muscle: Target organ (Placeholder short note)
- AMPK-PGC1α: Shared node (Placeholder short note)
- Biguanide: Drug class (Placeholder short note)
Placeholder heading: convergent pathway nodes
Placeholder short paragraph describing metformin and exercise convergence on AMPK.
Potential Blunting of Training Adaptation
Placeholder: co-administration may reduce mitochondrial adaptation gains.
- ~30–50%: Reported blunting (Placeholder short note)
- VO2max gain: Affected trait (Placeholder short note)
- RCT trials: Study design (Placeholder short note)
- Concurrent dosing: Risk driver (Placeholder short note)
Placeholder heading: blunted adaptation evidence
Placeholder short paragraph describing evidence for blunted training adaptation.
Placeholder highlight callout: blunting risk rises with concurrent high-intensity training.
Population-Specific Effect Size Differences
Placeholder: individual response to the interaction varies substantially.
- ~50/50: Responder split (Placeholder short note)
- SLC22A tx.: Genetic factor (Placeholder short note)
- Older > blunted: Age effect (Placeholder short note)
- Modifies effect: Fitness baseline (Placeholder short note)
Placeholder heading: variability across subgroups
Placeholder short paragraph describing population-specific variability drivers.
Timing Strategies to Minimize Interaction
Placeholder: separating metformin dosing from training may help.
- ≥3 h: Suggested gap (Placeholder short note)
- Dose separation: Strategy (Placeholder short note)
- Post-workout dose: Alt. strategy (Placeholder short note)
- Emerging: Evidence level (Placeholder short note)
Placeholder heading: practical timing recommendations
Placeholder short paragraph describing timing separation strategies.
Placeholder highlight callout: separating doses may preserve most training adaptation.